Endoscopic Versus Conventional Parotidectomy for Benign Parotid Tumors (NCT07600112) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Endoscopic Versus Conventional Parotidectomy for Benign Parotid Tumors
Egypt46 participantsStarted 2026-05-01
Plain-language summary
To compare endoscopic and conventional parotidectomy in the management of benign parotid tumors regarding surgical outcomes, facial nerve preservation, operative time, postoperative complications, and cosmetic results, in order to evaluate the safety, feasibility, and potential advantages of the endoscopic minimally invasive technique.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Adults aged 18 years or older
. Patients with benign parotid tumors involving the superficial lobe of the parotid gland
. Tumors located in the inferior pole with or without limited deep lobe extension
. Tumor size suitable for minimally invasive approach ≤4 cm
. Patients fit for surgery under general anesthesia
. Patients willing to provide informed consent and comply with follow-up
Exclusion criteria
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial compares endoscopic and conventional parotidectomy for benign parotid tumors — can you help me understand what the key differences are between these two surgical approaches, and which one you would recommend for my specific tumor?
2Since facial nerve function is one of the main things being measured in this trial, what is the current evidence on the risk of nerve damage with the endoscopic approach compared to the standard open surgery, and how might that affect my recovery?
3The trial is described as 'active but not recruiting' — does that mean enrollment is closed, and if so, is there any way I could still benefit from what this study is learning, or are there similar studies I could consider?
4Because this trial is categorized as phase NA and is focused on safety and feasibility, does that mean the endoscopic technique is still being established as safe rather than proven superior — and how should that influence my decision between this and conventional parotidectomy?
5Would standard conventional parotidectomy be just as good an option for me right now given what is already known, or is there a specific reason my care team might think the endoscopic approach being studied here is worth discussing for my situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Surgical safety and feasibility
Timeframe: During surgery and up to 3 months postoperatively.